ArticleAnnals of translational medicine2022

The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review.

Xianhua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.